Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Antitumor taxoids revealed

June 28, 1996

DepoCyt earns positive phase III results

June 28, 1996

SKI-2054R synthesized by Sunkyong

June 28, 1996

Agouron and Roche sign codevelopment agreement

June 28, 1996

Lu-Tex deemed safe and effective in phase I trial

June 21, 1996

TH-9402 covered under U.S. patent

June 21, 1996

Encouraging preclinical results for G-3139

June 21, 1996

Onyx and Lilly expand BRCA1 research agreement

June 21, 1996

Universidad de Salamanca reveals LL-15

June 21, 1996

Breast/prostate cancer treatment agents reported

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 13, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 12, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.